Specialty Pharmacy

FLINT, Mich. — Diplomat Specialty Pharmacy president and CEO Phil Hagerman has been named the Grant Thornton Leader & Innovator of the Year, Diplomat said Friday.

ARLINGTON, Va. — Distributors of specialty drugs save the healthcare industry an estimated $3.5 billion per year by using extensive measures to ensure safe delivery, according to a new report by the Center for Healthcare Supply Chain Research, the research foundation of the Healthcare Distribution Management Association.

RANCHO MIRAGE, Calif. — The New Life Agency has added a prescription progesterone supplement and RESOLVE: the National Fertility Association to the Fertility Pharmacy Care Card.

On top of its 101 in-store pharmacies, Schnucks last year opened four specialty pharmacies, offering specialized services to patients.


The pharmacies offer services for patients living with such chronic conditions as HIV, cancer, multiple sclerosis and autoimmune diseases, as well as for people recovering from organ transplants, said company spokesman Paul Simon. “It’s for patients who require special attention and hard-to-source medication,” he added.


REDWOOD CITY, Calif. — Drug maker AP Pharma has appointed two new executives and may receive financing of up to $4.5 million, the company said Monday.

AP announced the appointment of John Whelan as president, CEO and director, and Michael Adam as SVP and COO.


In the May issue of Consumer Reports, a report found that such independents as McKesson’s Health Mart franchise group are delivering the goods.


McKesson helped capitalize on what has always been an exemplary Health Mart patient experience at the top of last year with a multi-
million-dollar ad campaign that included an ad during the New Orleans Saints/Indianapolis Colts Super Bowl. That 2010 campaign featured real Health Mart pharmacists with stories on how they have impacted their local communities by taking the time to care and provide special services.


There’s nothing like a recession for focusing merchants on what matters most. For USA Drug, that meant concentrating on core markets, cutting costs and recharging its image for down-home value, neighborly service and a broadly merchandised front end focused on local consumer preferences.


WILMINGTON, Del. — Anglo-Swedish drug maker AstraZeneca has made the drug vandetanib available to certain thyroid cancer patients.

The drug maker announced Monday that the drug would be available to patients with medullary thyroid cancer that could not be removed surgically or that had spread to other parts of the body. The Food and Drug Administration approved the drug on April 6, and it is available exclusively through the pharmacy business unit of Biologics Inc., an integrated cancer management company.